- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01720589
Effect of Dietary Fat Cooking Blend on Energy Expenditure in Children (Melt)
May 28, 2013 updated by: Marie-Pierre St-Onge, St. Luke's-Roosevelt Hospital Center
Development of Rich & Creamy Melt® Organic Cooking Blend for Oxidative Stability and Reducing Childhood Obesity
The purpose of this study is to test the effects of a cooking oil blend of dietary fats rich in medium chain triglycerides on energy expenditure and food intake in overweight and obese children.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
5
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10025
- St. Luke's/Roosevelt Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age 15-18
- body mass index 85% percentile or higher for age/sex
- weight stable
Exclusion Criteria:
- ±5 lbs weight change in the the 3 months prior
- use of medications
- dietary allergies
- metabolic disorder
- eating disorder
- behavioral or psychological disorders
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Melt (test oil)
Participants will consume a muffin containing 20 g of dietary fat provided by the test oil and their energy expenditure will be measure post-prandially for 6 hours.
At the end of the measurement period, participants will consume a cookie containing 10 g of fat provided by the test oil and their food intake at an ad libitum meal will be measured 1 hour later.
|
|
|
Active Comparator: Corn oil (control)
Participants will consume a muffin containing 20 g of dietary fat provided by the control oil and their energy expenditure will be measure post-prandially for 6 hours.
At the end of the measurement period, participants will consume a cookie containing 10 g of fat provided by the control oil and their food intake at an ad libitum meal will be measured 1 hour later.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Thermic effect of food
Time Frame: 6 h
|
Measurement of thermic effect of food over 6 hours after a meal rich in test oil and control oil.
The thermic effect of food is the difference between post-prandial energy expenditure and basal energy expenditure.
We will assess the difference in thermic effect of food over a 6-hour period between the test oil and the control oil.
|
6 h
|
|
Respiratory quotient/fat oxidation
Time Frame: 6 h
|
Measurement of substrate oxidation by indirect calorimetry over 6 hours after consumption of the test oil and control oil.
We will specifically calculate carbohydrate and fat oxidation rates over the 6-hour period post-prandially and compare rates of oxidation of these two substrates between the test oil and the control oil.
|
6 h
|
|
Food intake
Time Frame: single meal
|
Measurement of food intake at a single meal served 1 hour after a pre-load containing 8-10 g of the test oil and the control oil
|
single meal
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Glucose
Time Frame: 6 h
|
Measurement of glucose over 6 hours after consumption of the test oil and control oil
|
6 h
|
|
Feelings of appetite and satiety
Time Frame: 6 h
|
Measurement of feelings of appetite and satiety by visual analog scales over 6 hours after consumption of the test oil and control oil
|
6 h
|
|
Insulin
Time Frame: 6 hours
|
Measurement of insulin over 6 hours after consumption of the test oil and control oil
|
6 hours
|
|
Leptin
Time Frame: 6 hours
|
Measurement of leptin over 6 hours after consumption of the test oil and control oil
|
6 hours
|
|
Ghrelin
Time Frame: 6 hours
|
Measurement of ghrelin over 6 hours after consumption of the test oil and control oil
|
6 hours
|
|
Peptide YY
Time Frame: 6 hours
|
Measurement of peptide YY over 6 hours after consumption of the test oil and control oil
|
6 hours
|
|
Glucagon like peptide 1
Time Frame: 6 hours
|
Measurement of glucagon like peptide 1 over 6 hours after consumption of the test oil and control oil
|
6 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Marie-Pierre St-Onge, Ph.D, St. Luke's-Roosevelt Hospital Center
- Principal Investigator: Cygnia Rapp, Prosperity Organic Foods
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2012
Primary Completion (Actual)
February 1, 2013
Study Completion (Actual)
February 1, 2013
Study Registration Dates
First Submitted
October 17, 2012
First Submitted That Met QC Criteria
October 31, 2012
First Posted (Estimate)
November 2, 2012
Study Record Updates
Last Update Posted (Estimate)
May 30, 2013
Last Update Submitted That Met QC Criteria
May 28, 2013
Last Verified
May 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2012-33610-19482
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Childhood Obesity
-
Universiteit LeidenWageningen University; Nutricia, Inc.; Danone ResearchCompletedChildhood Obesity | Childhood Overweight | Vegetable Acceptance in Early ChildhoodNetherlands
-
Cornell UniversityCompletedChildhood Obesity Prevention
-
Universidad de SonoraCentro de Investigación en Alimentación y Desarrollo A.C.; Instituto Nacional...Not yet recruitingChildhood Obesity Pevention
-
Tehran University of Medical SciencesUnknownChildhood Obesity PreventionIran, Islamic Republic of
-
Universidad Autonoma de Nuevo LeonUniversidad de la SabanaCompletedPrevention Childhood ObesityMexico
-
Oregon State UniversityCompletedChildhood Obesity Prevention
-
The Miriam HospitalHassenfeld Child Health Innovation InstituteCompletedChildhood Obesity PreventionUnited States
-
Fundacion para la Formacion e Investigacion Sanitarias...UnknownChildhood Obesity PreventionSpain
-
Tampere UniversitySeinajoki Central Hospital; Tampere University Hospital; Foundation for Paediatric... and other collaboratorsCompleted
-
Harokopio UniversityCompletedPrevention of Childhood ObesityGreece
Clinical Trials on Melt (test oil)
-
Columbia UniversityUnited States Department of Agriculture (USDA)CompletedObesity | Overweight | Pediatric ObesityUnited States
-
Helse FonnaTerminated
-
Franklin Health ResearchWithdrawnAnxiety | Autism Spectrum DisorderUnited States
-
BLIS Technologies LimitedRecruiting
-
The Cleveland ClinicRecruitingCardiovascular Risk Factor | Dietary ModificationUnited States
-
Ferring PharmaceuticalsCompleted
-
Stanford UniversityTerminatedStage IV Nasopharyngeal Carcinoma | Stage III Nasopharyngeal Carcinoma | Stage IVA Nasopharyngeal Carcinoma | Stage IVB Nasopharyngeal Carcinoma | Stage II Nasopharyngeal Carcinoma | Stage 0 Nasopharyngeal Carcinoma | Stage 0 Paranasal Sinus Cancer | Stage I Nasopharyngeal Carcinoma | Stage I Paranasal... and other conditionsUnited States
-
Semanur BilgiçNot yet recruitingCancerTurkey (Türkiye)
-
Harvard School of Public Health (HSPH)CompletedCardiovascular Disease
-
Réseau de Santé Vitalité Health NetworkCompleted